Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-15 4:44 pm Purchase | 2025-03-31 | 13G | Artiva Biotherapeutics, Inc. ARTV | venBio Global Strategic Fund III, L.P. | 1,198,975 4.900% | 1,198,975 (New Position) | Filing History |
| 2024-11-14 4:56 pm Unchanged | 2024-11-14 | 13G | Artiva Biotherapeutics, Inc. ARTV | venBio Global Strategic Fund III, L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-08-08 9:05 pm Unchanged | 2024-08-08 | 13D | Elevation Oncology, Inc. ELEV | venBio Global Strategic Fund III, L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-08-01 7:00 pm Unchanged | 2024-08-01 | 13G | Artiva Biotherapeutics, Inc. ARTV | venBio Global Strategic Fund III, L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-02-09 4:38 pm Unchanged | 2024-02-09 | 13G | RayzeBio, Inc. Common Stock RYZB | venBio Global Strategic Fund III, L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-01-24 6:41 pm Unchanged | 2024-01-24 | 13D | Pharvaris N.V. PHVS | venBio Global Strategic Fund III, L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-06-21 4:33 pm Unchanged | 2023-06-21 | 13D | Pharvaris N.V. PHVS | venBio Global Strategic Fund III, L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-06-15 4:30 pm Unchanged | 2023-06-15 | 13D | Elevation Oncology, Inc. ELEV | venBio Global Strategic Fund III, L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-01-30 5:25 pm Unchanged | 2023-01-30 | 13D | Ventyx Biosciences, Inc. VTYX | venBio Global Strategic Fund III, L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-12-15 5:00 pm Unchanged | 2022-12-15 | 13D | Ventyx Biosciences, Inc. VTYX | venBio Global Strategic Fund III, L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-09-26 4:24 pm Unchanged | 2022-09-26 | 13D | Pharvaris N.V. PHVS | venBio Global Strategic Fund III, L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-09-26 4:21 pm Unchanged | 2022-09-26 | 13D | Elevation Oncology, Inc. ELEV | venBio Global Strategic Fund III, L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-09-26 4:18 pm Unchanged | 2022-09-26 | 13G | CinCor Pharma, Inc. CINC | venBio Global Strategic Fund III, L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-09-14 5:01 pm Unchanged | 2022-09-14 | 13D | Ventyx Biosciences, Inc. VTYX | venBio Global Strategic Fund III, L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-05-27 5:26 pm Unchanged | 2022-05-27 | 13D | Elevation Oncology, Inc. ELEV | venBio Global Strategic Fund III, L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-01-11 4:46 pm Unchanged | 2022-01-11 | 13G | CinCor Pharma, Inc. CINC | venBio Global Strategic Fund III, L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2021-11-04 4:15 pm Unchanged | 2021-11-04 | 13D | Ventyx Biosciences, Inc. VTYX | venBio Global Strategic Fund III, L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2021-07-09 4:01 pm Unchanged | 2021-07-09 | 13D | Elevation Oncology, Inc. ELEV | venBio Global Strategic Fund III, L.P. | 0 0.000% | 0 (Unchanged) | Filing |